Literature DB >> 18237690

Combined metabolomic and proteomic analysis of human atrial fibrillation.

Manuel Mayr1, Shamil Yusuf, Graeme Weir, Yuen-Li Chung, Ursula Mayr, Xiaoke Yin, Christophe Ladroue, Basetti Madhu, Neil Roberts, Ayesha De Souza, Salim Fredericks, Marion Stubbs, John R Griffiths, Marjan Jahangiri, Qingbo Xu, A John Camm.   

Abstract

OBJECTIVES: We sought to decipher metabolic processes servicing the increased energy demand during persistent atrial fibrillation (AF) and to ascertain whether metabolic derangements might instigate this arrhythmia.
BACKGROUND: Whereas electrical, structural, and contractile remodeling processes are well-recognized contributors to the self-perpetuating nature of AF, the impact of cardiac metabolism upon the persistence/initiation of this resilient arrhythmia has not been explored in detail.
METHODS: Human atrial appendage tissues from matched cohorts in sinus rhythm (SR), from those who developed AF post-operatively, and from patients in persistent AF undergoing cardiac surgery were analyzed using a combined metabolomic and proteomic approach.
RESULTS: High-resolution proton nuclear magnetic resonance (NMR) spectroscopy of cardiac tissue from patients in persistent AF revealed a rise in beta-hydroxybutyrate, the major substrate in ketone body metabolism, along with an increase in ketogenic amino acids and glycine. These metabolomic findings were substantiated by proteomic experiments demonstrating differential expression of 3-oxoacid transferase, the key enzyme for ketolytic energy production. Notably, compared with the SR cohort, the group susceptible to post-operative AF showed a discordant regulation of energy metabolites. Combined principal component and linear discriminant analyses of metabolic profiles from proton NMR spectroscopy correctly classified more than 80% of patients at risk of AF at the time of coronary artery bypass grafting.
CONCLUSIONS: The present study characterized the metabolic adaptation to persistent AF, unraveling a potential role for ketone bodies, and demonstrated that discordant metabolic alterations are evident in individuals susceptible to post-operative AF.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18237690     DOI: 10.1016/j.jacc.2007.09.055

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  77 in total

Review 1.  Epidemiology of Atrial Fibrillation in the 21st Century: Novel Methods and New Insights.

Authors:  Jelena Kornej; Christin S Börschel; Emelia J Benjamin; Renate B Schnabel
Journal:  Circ Res       Date:  2020-06-18       Impact factor: 17.367

Review 2.  Proteomics and transcriptomics in atrial fibrillation.

Authors:  Marc Sühling; Carmen Wolke; Christian Scharf; Uwe Lendeckel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2018-01-09

3.  Development of a novel proteomic approach for mitochondrial proteomics from cardiac tissue from patients with atrial fibrillation.

Authors:  Maryam Goudarzi; Mark M Ross; Weidong Zhou; Amy Van Meter; Jianghong Deng; Lisa M Martin; Chidima Martin; Lance Liotta; Emanuel Petricoin; Niv Ad
Journal:  J Proteome Res       Date:  2011-07-08       Impact factor: 4.466

Review 4.  Proteomics in heart failure: top-down or bottom-up?

Authors:  Zachery R Gregorich; Ying-Hua Chang; Ying Ge
Journal:  Pflugers Arch       Date:  2014-03-13       Impact factor: 3.657

Review 5.  Translating metabolomics to cardiovascular biomarkers.

Authors:  Todd Senn; Stanley L Hazen; W H Wilson Tang
Journal:  Prog Cardiovasc Dis       Date:  2012 Jul-Aug       Impact factor: 8.194

6.  Fenofibrate inhibits atrial metabolic remodelling in atrial fibrillation through PPAR-α/sirtuin 1/PGC-1α pathway.

Authors:  Guang-Zhong Liu; Ting-Ting Hou; Yue Yuan; Peng-Zhou Hang; Jing-Jing Zhao; Li Sun; Guan-Qi Zhao; Jing Zhao; Jing-Mei Dong; Xiao-Bing Wang; Hang Shi; Yong-Wu Liu; Jing-Hua Zhou; Zeng-Xiang Dong; Yang Liu; Cheng-Chuang Zhan; Yue Li; Wei-Min Li
Journal:  Br J Pharmacol       Date:  2016-02-18       Impact factor: 8.739

7.  Proteomic identification of biomarkers of vascular injury.

Authors:  Ngan F Huang; Kyle Kurpinski; Qizhi Fang; Randall J Lee; Song Li
Journal:  Am J Transl Res       Date:  2010-11-21       Impact factor: 4.060

8.  High Plasma Glutamate and a Low Glutamine-to-Glutamate Ratio Are Associated with Increased Risk of Heart Failure but Not Atrial Fibrillation in the Prevención con Dieta Mediterránea (PREDIMED) Study.

Authors:  Christopher Papandreou; Pablo Hernández-Alonso; Mònica Bulló; Miguel Ruiz-Canela; Jun Li; Marta Guasch-Ferré; Estefanía Toledo; Clary Clish; Dolores Corella; Ramon Estruch; Montserrat Cofán; Montserrat Fitó; Cristina Razquin; Fernando Arós; Miquel Fiol; José M Santos-Lozano; Lluís Serra-Majem; Liming Liang; Miguel A Martínez-González; Frank B Hu; Jordi Salas-Salvadó
Journal:  J Nutr       Date:  2020-11-19       Impact factor: 4.798

Review 9.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

Review 10.  Application of metabolomics to cardiovascular biomarker and pathway discovery.

Authors:  Gregory D Lewis; Aarti Asnani; Robert E Gerszten
Journal:  J Am Coll Cardiol       Date:  2008-07-08       Impact factor: 24.094

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.